BetterLife Pharma (STU:NPAU) EPS (Basic): €-0.01 (TTM As of Jan. 2026)


What is BetterLife Pharma EPS (Basic)?

BetterLife Pharma STU:NPAU +13.64% EPS (Basic) is €-0.01 as of Jan. 2026.

BetterLife Pharma's basic earnings per share (Basic EPS) for the three months ended in Jan. 2026 was €0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2026 was €-0.01.

BetterLife Pharma's EPS (Diluted) for the three months ended in Jan. 2026 was €0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 was €-0.01.

BetterLife Pharma's EPS without NRI for the three months ended in Jan. 2026 was €0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2026 was -0.01.

During the past 3 years, the average EPS without NRI Growth Rate was 47.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 45.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 35.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, BetterLife Pharma's highest 3-Year average EPS without NRI Growth Rate was 51.60% per year. The lowest was -349.50% per year. And the median was 39.60% per year.

BetterLife Pharma  (STU:NPAU) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

BetterLife Pharma EPS (Basic) Related Terms

BetterLife Pharma EPS (Basic) Historical Data

* Premium members only.

The historical data trend for BetterLife Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BetterLife Pharma EPS (Basic) Chart

BetterLife Pharma Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.11 -0.07 -0.02 -0.02 -0.01

BetterLife Pharma Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Jan26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.01 0.00 -0.00 0.00

BetterLife Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

BetterLife Pharma's Basic EPS for the fiscal year that ended in Jan. 2026 is calculated as

Basic EPS (A: Jan. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.924-0)/145.880
=-0.01

BetterLife Pharma's Basic EPS for the quarter that ended in Jan. 2026 is calculated as

Basic EPS (Q: Jan. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0-0)/145.880
=0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €-0.01 mean?
BetterLife Pharma (STU:NPAU) has a EPS (Basic) of €-0.01 as of Jan. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on BetterLife Pharma and its competitors.
Is BetterLife Pharma's EPS (Basic) too high?
BetterLife Pharma's current EPS (Basic) is €-0.01.
How does BetterLife Pharma's EPS (Basic) compare to VRTX and REGN?
BetterLife Pharma's EPS (Basic) of €-0.01 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on BetterLife Pharma and its competitors. BetterLife Pharma's current EPS (Basic) is €-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BetterLife Pharma stock overvalued right now?
BetterLife Pharma (STU:NPAU) has a current EPS (Basic) of €-0.01. The current EPS (Basic) is €-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For BetterLife Pharma (STU:NPAU), the current EPS (Basic) is €-0.01 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BetterLife Pharma Business Description

Other Exchanges BETRF:USABETR:Canada
Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.